Health Technology and AI News

PLEASANTON, CA–(Marketwire – December 3, 2010) – Callidus Software (NASDAQ: CALD)

WHO:

G. F. “Will” Williams, senior incentive compensation analyst, Philips Healthcare

WHAT:

Is your workforce delivering the results that you need? Are they truly aligned with your top-tier business objectives? Learn how best-in-class organizations outperform competitors by using Management-by-Objective (MBO) programs to drive business performance.

WHEN:

Thursday, December 9, 2010

11 a.m. Pacific / 1 p.m. Central / 2 p.m. Eastern Time

WHERE:

To register for the event and for additional information go to:
http://www2.callidussoftware.com/Q410-MBO-Webinar.html

If you cannot attend the live event, please register and we will send you the on-demand version when available.

In the webinar, you will learn:

• Best practices in developing and administering MBOs
• How to develop MBOs that motivate employees and drive them toward accomplishing top-tier corporate objectives
• How to enhance employee engagement
• How to overcome common challenges that can potentially hinder your success

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG) (AMS: PHI), which includes Philips Healthcare, is a diversified health and well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs more than 116,000 employees in more than 60 countries worldwide. With sales of EUR 23 billion in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

About Callidus Software®

Callidus Software (NASDAQ: CALD) is the market and technology leader in Sales Performance Management (SPM). Callidus customers gain a competitive advantage by maximizing sales cost efficiencies and driving improvements in sales effectiveness. Our award-winning Software-as-a-Service (SaaS) applications set the standard for performance management of a company’s sales force and channel partners. Over 2 million employees and channel partners have their performance managed by Callidus Software. For more information, please visit www.callidussoftware.com.

©1997-2010 Callidus Software Inc. All rights reserved. Callidus Software, the Callidus Software logo, and TrueComp Manager are trademarks, service marks, or registered trademarks of Callidus Software Inc. in the United States and other countries. All other brand, service or product names are trademarks or registered trademarks of their respective companies or owners.

Click here to see all recent news from this company

BISHOPS STORTFORD, UNITED KINGDOM–(Marketwire – Dec. 2, 2010) – Dotmatics, a provider of information and data management solutions to the life sciences industry, is pleased to announce that it has moved into new UK headquarters. Situated in the centre of Bishops Stortford, The Old Monastery is a historic building (link) built in the 17^th Century.

Stephen Gallagher, Chief Executive Officer of Dotmatics said, “Moving the company to new headquarters marks a new and important milestone for the company. We have seen significant growth in demand for our solutions over the past few years. Expansion into new premises allows us to continue to provide excellent support and development capabilities.”

About Dotmatics

Dotmatics has rapidly emerged as a preferred Informatics supplier to many of the top global Pharma and Biotech organisations. Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, browsed, managed and shared within companies. Dotmatics has significant expertise in cheminformatics techniques including chemical databases, SAR analysis, data management and data visualization. A privately-owned company, Dotmatics was founded in 2005 and has its head office based south of Cambridge, UK.

Recent Corporate Highlights Include:

Fully web based and searchable ELN launched at EUGM.

http://www.dotmatics.com/news.jsp#id94

Dotmatics opens second U.S. office near Boston Mass.

http://www.dotmatics.com/news.jsp#id93

Heptares Therapeutics chooses Dotmatics platform.

http://www.dotmatics.com/news.jsp#id90

Boehringer Ingelheim license Browser and Vortex.

http://www.dotmatics.com/news.jsp#id81

Spanish Giant Almirall choose Dotmatics for Visualisation

http://www.dotmatics.com/news.jsp#id92

Solution Highlights:

Browser – web-based tool for querying, browsing and visualizing biological databases such as IDBS’ ActivityBase™ and any chemical database.

Vortex – world-class visualization and analytics platform for scientific and non-scientific data.

Gateway – securely enables research teams to share information internally and with external partners.

Pinpoint – powerful Oracle chemical cartridge for querying and integrating chemical databases^*. Pinpoint represents world-class indexing and search performance at a cost-effective price.

Register – flexible and scalable chemical registration system.

Nucleus – map and import biological and non-biological data files into an Oracle database.

Studies – the new standard in screening data management.

Studies Notebook – a web-based ELN for all disciplines.

*Pinpoint is developed in collaboration with Astex Therapeutics Ltd

POWAY, CA–(Marketwire – December 1, 2010) – Vet-Stem, the world’s leading Regenerative Veterinary Medicine™ company, is pleased to announce a new milestone of 4,000 horses treated with Vet-Stem Cell therapy.

Vet-Stem began providing stem cells to veterinarians in 2004 and has now provided stem cells for the treatment of 4,000 horses. Greater than 75% of horses treated with Vet-Stem Cell therapy for tendon and ligament injuries are able to return to their previous level of performance. What was a new treatment option in 2004 has become the gold standard for performance horses with tendon and ligament injuries.

“We are proud that so many horse owners and veterinarians have placed their trust in Vet-Stem Cell therapy. We feel a great sense of accomplishment knowing that there are thousands of horses and horse owners who have experienced the benefit of stem cell technology. This practical and beneficial application of technology puts stem cell therapy into the present day instead of a future theoretical concept,” said Bob Harman, DVM, MPVM, Founder and CEO of Vet-Stem.

Vet-Stem has also provided stem cells for thousands of dogs with arthritis with a similar success rate. The rapid adoption of stem cell therapy by equine veterinarians and horse owners provided a springboard for use in small animal veterinary medicine. Vet-Stem is now working with small animal veterinarians to develop uses for stem cell therapy for injuries and diseases that currently have few treatment options.

More information about Vet-Stem can be found at www.Vet-Stem.com.

About Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. Vet-Stem has exclusive licenses to over 50 patents including worldwide veterinary rights for use of adipose derived stem cells.

Click here to see all recent news from this company

ORLANDO, FL–(Marketwire – December 1, 2010) – WellTek, Inc. (OTCBB: WTKN), a global health, fitness and wellness company, announced today that it plans to expand into the virtual event market, specializing in the healthcare and wellness niche, by launching a new wholly-owned company, WellTek Events, Inc. This next-generation virtual event platform will serve as the foundation in allowing WellTek and other brands to actively reach, engage and influence health and wellness conscious consumers with new and existing brand assets, technologies, products and services.

According to the Virtual Conference and Trade Show Market Study 2010-2015, the worldwide virtual conference and trade show market is forecasted to grow at a compound annual growth rate (CAGR) of 56% between the period of 2010 and 2015 and to generate $18.6 billion in revenues over the period 2010 – 2015. While the virtual event market is still in its infancy, WellTek intends to launch into the virtual event business.

WellTek Events is looking to become the industry leader in producing and delivering powerful virtual events for the healthcare and wellness market — linking exhibitors, attendees, and thought leaders together in a fully immersive and engaging virtual environment. 

Without the costs, hassles and time involved in a physical event, participants navigate through the 3D game-like world booth by booth via an avatar. Advances in technology allow exhibitors to actively reach, engage and influence a highly targeted global audience, create and customize virtual booths, communicate with prospects via video conferencing and live chat, convert leads to customers in real-time with the Ecommerce platform, generate reports and analytics to tract ROI and many more features that ultimately turn prospects into buyers and customers into raving fans.

The integration of virtual events, social networking and social gaming permits attendees to overcome the challenges facing the traditional trade show market, as well as take advantage of the benefits of social media: staying in constant contact, sharing opinions, recommendations and links, getting answers right away and feeling connected to the information they care most about — all while being entertained.

Randy Lubinsky, Chairman and CEO of WellTek, stated, “With over 40 years experience in the medical industry and interacting with physicians, we believe we can leverage our expertise to establish WellTek Events as the premiere company for virtual medical conferences and wellness events.”

In an effort to focus time and capital on WellTek Events, the company has decided to rescind the acquisition of its 51% interest in WellCity, Inc. As part of the rescission, 14,500,000 shares of WellTek common stock will be returned to WellTek and the financial position of both companies will return to that prior to the May 1, 2010 acquisition.

In addition, WellTek has also effectuated a 50 to 1 reverse split as of December 2, 2010 in order to facilitate raising additional growth capital.

About WellTek Incorporated
WellTek is a global health, fitness and wellness company that provides proven solutions to help address some of the world’s most pressing and costly health and wellness challenges. The Company owns and operates WellTek Events, Inc., a fully engaging virtual event platform specializing in the healthcare and wellness market. The Company’s subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. For more information on the Company, please contact [email protected] or visit www.WellTekinc.com. 

Certain statements contained in this press release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company’s Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company’s ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel — including highly qualified executives, management and operational personnel, ability to negotiate favorable future debt facilities and capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will, in fact, occur. 

MISSION, KS–(Marketwire – December 1, 2010) – PPM Information Solutions, Inc. (PPMIS) (www.ppmconnect.com) publishes “The Practice Readiness Roadmap — your route to a successful start.” Dedicated to serving the anesthesia community, PPMIS is forging its presence in the medical community and delivering its guide for assisting physicians who are considering starting a practice or moving to a new software vendor or billing service. Download a free copy.

For over a decade, PPMIS has developed first-rate software for medical billing solutions. Formed by anesthesiologists to serve the anesthesia specialty, the company’s goal is providing its clients with industry-leading software products and services. Because PPMIS understands the complexity of billing for anesthesia, its products and services take the everyday complications out of medical billing.

The company’s newest platform, a SaaS model, is medical billing software with flexibility, a full range of reporting options, and strictly enforced exception edits, ensuring claim accuracy that result in prompt reimbursement. The fully integrated Connect platform provides accelerated claims processing, streamlined collections management, and reporting capabilities.

RCM Services, its full-service medical billing service, offers multi-specialty billing, certified coding, SaaS technology, demographic and EMR downloads, payer credentialing, and practice advocacy. Proven metrics ensure the success of the client’s practice. The company believes when the client succeeds, it succeeds. Learn more about PPMIS practice management services.

About PPM Information Solutions, Inc.
PPMIS is a medical billing provider that helps clients recognize revenue faster by submitting clean claims. The company offers both billing software and billing services as its medical billing solutions. This U.S. based company does 100% of its software development at its headquarters in Mission, KS. Its staff is dedicated to delivering the most comprehensive solutions available for medical billing. PPMIS billing solutions and the Practice Readiness Roadmap free practice assessment can be found at www.ppmconnect.com.

Direct inquiries to [email protected], or contact Manolito Jones or Dan Olin at 913-262-2332 to request a product demonstration.

Click here to see all recent news from this company

NEW YORK, NY–(Marketwire – November 29, 2010) – MedLink (OTCBB: MLKNA), a leading provider of health information technology solutions, today announced that it has closed an aggregate of $2.25 million in financing. Aegis Capital Corp, sole placement agent and exclusive investment banker to MedLink, placed $1.0 million through a private placement, and an additional $1.25 million in capital through the sale of convertible notes sold exclusively to institutional investors. The investment capital proceeds will be used to fund increased sales and marketing, working capital needs of the Company, and the acquisition of MedAppz which was announced earlier this month.

“We are extremely pleased to have the support of our investors who affirm our corporate vision, and the overwhelming interest in the offering is a testament to the MedLink team and the cutting edge technology we are providing to the healthcare market,” said Ray Vuono, CEO of MedLink International, Inc. “With this financing, the company is well positioned to deliver its suite of Electronic Health Record (EHR) and Healthcare Information Technology communication platforms, to meet the increasing demand of the industry as healthcare facilities of all sizes are adopting EHR technology to take advantage of the efficiencies and the incentives both on a State and Federal level.”

David Bocchi, Director of Investment Banking at Aegis Capital, said, “MedLink represents a rare and exciting opportunity in a competitive and consolidating space where it continues to demonstrate it has the tools and resources necessary to successfully become an industry leader.” He added, “The management team was instrumental in swiftly securing the capital in a placement with overwhelming investor demand, and we look forward to providing the company with the continued support necessary to assist in its growth.”

About MedLink

MedLink is a healthcare IT company providing the medical community with products and services for the creation, management, and sharing of medical information. The company’s flagship product, MedLink TotalOffice EHR 3.1, a CCHIT Certified® 08 Ambulatory EHR, provides physicians with full EHR and practice management functionality. For more information regarding MedLink’s products and services, please visit www.medlinkus.com.

About Aegis

Aegis Capital is a full-service boutique brokerage operation focused on middle-market corporate finance, research, and valuation services. Aegis actively manages over $2 billion of retail customer assets with over 200 registered representatives in 8 corporate locations. Aegis Capital Corporation was founded in 1984 by Robert Eide, the current CEO and Chairman. Its origins were based on servicing the specific needs of an extremely affluent customer base. For more information, please visit the Aegis website at www.aegiscapcorp.com.

Safe Harbor Statement

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, outlined in our 2009 Annual Report on Form 10-Kavailable through www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

PALO ALTO, CA–(Marketwire – November 28, 2010) – Fovia, Inc., a leader in volume rendering technology, has demonstrated the scalability of its High Definition Volume Rendering® software on the newest generation of Apple® computers. Fovia’s HDVR® software performed 1.5x faster on a Mac Pro 12-core 2.93GHz than it did on a Mac Pro 8-core 2.93GHz (Apple’s previous generation), thereby showcasing perfect, core-for-core scalability. The benchmarking results can be found on Apple’s website at http://www.apple.com/macpro/performance.html.

Fovia’s HDVR algorithms and architecture take full advantage of the future directions in both imaging and computing (larger datasets, larger projection displays, multi-core processors, multi-threading, multi-CPU environments and server-side rendering for thin-clients) without sacrificing quality or performance. This scalability has been, and will continue to be, critical to ensuring the long-term superiority of Fovia’s solution. 

George Buyanovsky, Fovia’s President and C.T.O., remarked, “The highly-efficient multi-core scalability of HDVR has been a major focus of Fovia’s rendering technology. Our CPU-based Volume Ray Casting algorithms very effectively utilize available CPUs resources; therefore, the evolution of general purpose CPUs toward multi-cores and multi-threading are increasingly beneficial for our clients, and we are pleased that our benchmarking results have been published by such a well-respected third party.”

Fovia’s scalable, software-only solution has unparalleled interactive image quality, superior performance, and better memory utilization than other products currently available — including expensive, hardware-based approaches. In addition to its extraordinary scalability with respect to processor performance, Fovia’s HDVR® engine scales with both the exponentially increasing amount of data being generated by modern scanners, and with the continuing growth of larger and higher definition displays now being used for more accurate viewing.

About Fovia, Inc.

Fovia, Inc. was founded in 2003 to address the challenges of data explosion — the exponentially increasing amount of data being acquired by modern imaging modalities. The firm has developed a CPU-based, High Definition Volume Rendering® software solution that leverages and scales with multi-core, multi-processor and multi-threaded generational processor development. Fovia’s HDVR® solution is more scalable, cost effective, flexible, and easily deployable on an enterprise-wide basis than GPU or other hardware-based approaches and can be easily and natively integrated into various original equipment manufacturers’ offerings, therefore allowing OEMs to quickly and cost-effectively offer the world’s most advanced volume rendering to their customers.

For additional information, visit www.fovia.com.

Apple is a registered trademark of Apple Inc.

Fovia, High Definition Volume Rendering and HDVR are registered trademarks of Fovia Inc.

FALLS CHURCH, VA–(Marketwire – November 24, 2010) – The Workgroup for Electronic Data Interchange (WEDI) and Accredited Standards Committee X12 (ASC X12), today released two documents, “Companion Guide Principles – Guidelines and Conventions for the Development of Proprietary Companion Guides to supplement published ASC X12 Implementation Guides” and the associated “Standard Companion Guide Transaction Information Template.”

The Principles Document clarifies the requirements for creating proprietary Companion Guides based on ASC X12’s published implementation guides. The Companion Guide Template is used to ensure a consistent look and feel with consistent content across the companion documents developed by various entities in the health care industry. 

A third document, the Communication/Connectivity Instructions template, is being finalized, and will be released soon.

Jim Schuping, Executive Vice President/CEO of WEDI, stated: “We are very pleased to have had the opportunity to collaborate with ASC X12 on the development and publication of these important documents. They will serve as a very useful tool and guideline to our respective memberships and the industry.”

“The Companion Guide Principles and Template documents will help several types of health care entities,” said Cathy Sheppard, Chair, ASC X12. “They will help those that create companion guides develop documents with all the needed information quickly and consistently and they will help those that use those companion guides by ensuring information from many sources has the same look and feel and the consistent content.”

You can download both of these free documents at http://store.x12.org/x12ip/cg.htm.

About WEDI
Workgroup for Electronic Data Interchange is a non-profit healthcare association dedicated to promoting the standardization of healthcare data and the implementation of administrative simplification in healthcare. WEDI’s membership includes providers, payers, integrated delivery networks, vendors, consumers, government organizations and standards groups. WEDI helped to secure the passage of the Health Insurance Portability and Accountability Act (HIPAA) in 1996, and was designated as an official Advisor to the Secretary in the legislation, acknowledging its influence and unique position in the healthcare industry. For additional information, visit www.wedi.org.

About ASC X12
ASC X12, chartered by the American National Standards Institute more than 30 years ago, develops and maintains EDI and CICA standards along with XML schemas which drive business processes globally. The diverse membership of ASC X12 includes technologists and business process experts, encompassing health care, insurance, transportation, finance, government, supply chain and other industries. For additional information, visit www.x12.org.

TAMPA, FL–(Marketwire – November 23, 2010) – Zimek Technologies, the industry leader in infection control and biohazard remediation, released its new corporate video which is available on the Zimek website (http://www.zimek.com/media.asp) or YouTube (http://www.youtube.com/watch?v=bGpOTrsTRQ8).

“Zimek’s new corporate video will allow visitors to gain a meaningful understanding of the ‘Perfect Storm’ of antibiotic-resistant microbes currently afflicting our society on a daily basis, and how Zimek’s technology is a vital part of the solution,” said Kurt Grosman, CEO of Zimek Technologies. “Zimek’s 21^st Century infection control technology has the ability to access infectious pathogens wherever free air flows in an enclosed environment. This is achieved with micro-droplets of EPA-registered disinfectants in sizes equivalent to bacteria, viruses, and fungi, thereby effectively killing and reducing the spread of infectious microbes before they infect their victims.”

Zimek’s corporate video also provides expert testimony by Brad Spellberg, MD, the highly-regarded infectious disease specialist, scientist, and researcher at the David Geffen School of Medicine at UCLA and Harbor/UCLA Medical Center in Los Angeles, California and author of “Rising Plague.” Additional footage is included from Zimek Advisory Board Members Hon. Emil Jones, Jr. and James Lee Witt, Florida Governor-Elect Rick Scott, and Zimek customers.

Zimek Technologies, based in Tampa, Florida, has been developing and marketing its patented automatic Micro-Mist^® decontamination technology for more than five years. Zimek’s industry-leading technology is used by the U.S. Department of Homeland Security, U.S. Department of Defense, U.S. Department of Veteran Affairs, fire and EMS departments, healthcare facilities, public health agencies, transit systems, correctional facilities, and local law enforcement agencies across America. For more information, please visit www.zimek.com.

SUNNYVALE, CA–(Marketwire – November 22, 2010) – Healthmed Services, Ltd. (PINKSHEETS: HEME) announced that it has entered into a software development agreement with Veritas Software Systems. Veritas will produce for Healthmed 10 exclusive healthcare software suite systems by December 2011. “Healthmed is committed to bridging the information technology gap that plagues doctor, patient, and practice related issues that keep professionals and patients from experiencing the highest level of care and efficiency,” stated CFO Dale Paisley. Healthmed will continue to be committed to expanding its inventory of products to meet every aspect of efficiency and care, in additional to maximizing internal corporate growth and profitability.

Please read more about the Company and its product developments on its website: www.healthmedltd.com.

Notice Regarding Forward-Looking Statements

This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed with the Securities and Exchange Commission.

WARREN, NJ–(Marketwire – October 28, 2010) –  Health care reform has spawned a host of privacy, information security and other liability exposures for the emerging healthcare information technology industry. In response, the Chubb Group of Insurance Companies has established a program to address the industry’s specialized risk needs.

“Chubb has brought together its information and network technology and life sciences expertise to tailor insurance and loss control solutions to this rapidly growing market sector,” said Stephen Harris, a Chubb vice president and co-program manager.

More than 1,000 companies supply information technology products and services to the healthcare and medical research industries in the United States and Canada. The sector is poised for additional growth after the allocation of nearly $20 billion in federal stimulus funds to incentives to create electronic health records and to other investments in the sector.

“Chubb’s Healthcare Information Technology program will provide insurance products and services, on a global basis, that can help this emerging industry face privacy and information security requirements, as well as a host of new professional liability exposures,” said Richard Reed, a Chubb vice president and co-program manager.

An integrated liability solution from Chubb can help protect healthcare information technology companies from:

• general and products liability when software or hardware that is defective or contains inaccurate or incomplete information causes or contributes to patient injuries;
• errors and omission liability when a product defect or service deficiency results in economic injury to a customer;
• third-party liability to patients, healthcare providers and others associated with database security breaches; and
• costs incurred to comply with state, federal and foreign laws requiring companies to notify consumers of a privacy data breach.

In addition, Chubb can provide these firms with insurance addressing property, business interruption, workers compensation and auto exposures.

The member insurers of the Chubb Group of Insurance Companies form a multi-billion dollar organization providing property and casualty insurance for personal and commercial customers worldwide through 8,500 independent agents and brokers. Chubb’s global network includes branches throughout North America, Europe, Latin America, Asia and Australia.

SUN VALLEY, CA–(Marketwire – October 28, 2010) –  XTend Medical, (PINKSHEETS: XMDC), a company that specializes in delivering life changing medical technology to healthcare organizations globally, announced today that the company will soon be launching a new website within the next few weeks. The company issued the following statement:

“XTend has contracted with GoDaddy’s website design professionals to build a new website for the company. After the issues they ran into last year using an independent web developer, the need for professionally trained web engineers and graphics persons was instrumental in their decision to have the GoDaddy Team of experts build out the site. The information has been sent to the website team and we’re awaiting the Beta version so we can make any last minute changes before launching the new site. We expect to have the site live within the next week or so and feel this new site will properly represent the company in cyberspace.”

In other news, the company is working to position itself so the auditing process for becoming a fully reporting company is met and the company is strategically positioned to attract the proper investment structure to commercialize the BioHarp. Any changes made to the company will be done in accordance with corporate counsel’s advice and with the future of the company and its shareholders securely in the minds of management. 

About XTend Medical
XTend Medical is a company that specializes in the sales, manufacturing and distribution of the latest in medical devices and telemedicine solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their recent acquisition of the BioHarp medical device will assist the company in becoming known as a leader in the healthcare sector globally. For further information, please contact them at [email protected] or visit their website at www.bioharpunius.com

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

SAN FRANCISCO, CA–(Marketwire – October 27, 2010) –  Speech therapy is an industry that has historically shown limited adoption of technology, unlike most health care fields. The inability to produce speech sounds correctly affects approximately 6% of school age children. Articulate Technologies, Inc., has just launched Speech Buddies — a new line of products to help young children overcome speaking disorders. Speech Buddies (www.speechbuddy.com) are a new kind of helper: a family of practical, handheld devices that accelerate learning with the hardest problem sounds: R, S, L, CH, and SH.

Speech Buddies work by providing targets inside the mouth for children to feel correct tongue placement when attempting to pronounce problem sounds. Speech Buddies can quickly help children turn their Wabbits into Rabbits, Wessons into Lessons, and Thocks into Socks. This tactile feedback within the mouth is often just what kids need to achieve learning breakthroughs.

Parents can choose to use Speech Buddies at home with their child or bring their Buddy to speech therapy lessons with the goal of accelerating learning and correcting problem sounds.

“Parents and children have been thrilled about Speech Buddies and this new approach has been well received by the professional community,” says Gordy Rogers, M.S. CCC-SLP, speech therapist and Chief Scientific Officer of Articulate Technologies. “For years, speech professionals have not had the benefit of technology in their treatment of speech disorders and have used household items like coffee stirrers, spoons, and peanut butter to try and help their clients. Speech Buddies are more sophisticated, produce better outcomes, and are applicable to a wide variety of cases. Getting parents involved in the learning process either on their own at home or in combination with traditional therapy, gives families a sense of empowerment as they see improvement quickly.”

Speech Buddies were invented by a pair of high school classmates who put together an interdisciplinary team of MIT engineers and speech therapists across the country to help develop the solution. After hundreds of prototypes and refinements over the course of several years, the first-in-class system is finally accessible to both parents and speech therapists. Prices range from $149 for single Speech Buddies (R, S, L, CH or SH) to $299 for the Professional Set of all five Speech Buddies.

A clinical trial, INTACT (Intra-Oral Tactile Biofeedback), is currently underway to examine the efficacy of Speech Buddies in children aged 5-8 years old. It is a randomized, controlled, single blind clinical study; preliminary results are extremely encouraging and peer reviewed publication is pending.

Visit www.speechbuddy.com for information and videos on how Speech Buddies work.

DENVER, CO–(Marketwire – October 26, 2010) – Dean Evans & Associates, Inc. (www.dea.com), maker of the EMS line of facility and resource scheduling software, has completed an ambitious benchmarking survey initiative that will provide participants with valuable metrics on their meeting and event management operations.

More than 150 customers filled out the inaugural Facilities and Services Benchmark Survey, which is believed to be the first cross-industry survey of its kind, as it provides comparison data both within the participant’s industry and across the many industries that DEA serves. While detailed results will only be sent to participants, an Executive Summary is available to the public.

“We deeply appreciate the eagerness participants showed and the time they invested in answering the benchmark survey questions. As a result, we’re able to offer important data to our current and future customers,” said Kevin Raasch, vice president of Dean Evans & Associates. “Each participant can use their customized survey report as a yardstick to measure their performance and identify areas for improvement.”

The survey compared individual organizations’ key metrics, such as bookings-to-scheduling staff ratios, overall space utilization and service order numbers with their industry standards as well as with responses across all industries, generating powerful insights into facility scheduling best practices.

“Individual measurements such as number of bookings per year, number of staff members by job function and average hours of operation per day can be very helpful in and of themselves,” said Raasch. “But combining two or more of those numbers to get stats like the number of hours per day that your scheduling staff spends making reservations or the average number of service orders that each of your catering staff members is involved in each day can be very enlightening — especially when compared to other organizations in your industry.”

The survey also asked a number of subjective questions including some designed to identify trends. Event volume expectations, desired software integrations and anticipated shifts in technology were among them.

The 2011 Facilities and Services Benchmark Survey will be sent to customers and selected prospective customers next spring. To request a free copy of the Executive Summary from this year’s survey, please visit www.dea.com and click Benchmark Survey Summary under Quick Links.

MASON CITY, IA–(Marketwire – October 25, 2010) – CURRIES Hollow Metal Doors and Frames, an ASSA ABLOY Group brand and an industry leader, is pleased to announce the availability of MicroShield^® antimicrobial technology on all factory finished doors and frames.

Bacterial contamination is an important issue in hygiene-sensitive facilities such as hospitals, clinics, and schools. Safeguarding your building with surfaces that suppress bacteria growth between normal cleaning procedures can be an extra countermeasure in the fight against the spread of germs. MicroShield antimicrobial technology is a silver-based resin that continuously destroys organisms in three ways — by attacking the cell wall, interrupting metabolism, and preventing reproduction.

CURRIES embeds the antimicrobial properties into the painting process so this durable finish won’t rub off. “MicroShield technology gives our customers and end-users another barrier of protection in the fight against the spread of germs and bacteria,” says Dean Peterson, Director of Sales Administration. “And with the coating already applied to the prefinished doors when they arrive at the job site, the protection process is seamless to everyone involved.”

When combined with the MicroShield offerings from ASSA ABLOY Group hardware brands, CURRIES MicroShield doors and frames will provide any facility with a total door opening antimicrobial solution.

For more information on CURRIES MicroShield doors and frames, please visit our website at www.curries.com or contact your local ASSA ABLOY Door Security Solutions sales team.

About CURRIES
Founded in 1958, CURRIES is an industry leader in the manufacture of hollow metal doors and frames. The company supplies a full line of custom and standard products for new and retrofit construction projects in the commercial, educational and healthcare markets. For more information, visit www.curries.com.

About ASSA ABLOY 
ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user demands for security, safety and convenience.

Click here to see all recent news from this company

SAN CLEMENTE, CA–(Marketwire – October 25, 2010) –  Micro Identification Technologies, Inc. (OTCBB: MMTC) (MIT) announces that on October 27, 2010 at 1:00 PM (PDT) it will conduct a Webinar on the operation of the MIT 1000 Rapid Microbial Identification System. The objective of the Webinar is to demonstrate the speed and operational simplicity of performing bacteria identification (ID) tests using the MIT 1000 System and to give a brief education on the non-biological light scattering technology that is used to obtain an ID. The Webinar will be conducted by MIT’s Chief Technical Officer, Dr. David Haavig. Attendees may register for the Event at https://www3.gotomeeting.com/register/183951526. 

Michael Brennan, MIT’s Chairman and CEO, stated that “Based on feedback from current users and investors regarding our last Webinar, MIT plans to provide periodic Webinars to update the Company’s business and product achievements.” Mr. Brennan further stated, “We are certain the attendees at our upcoming Webinar will be impressed with both the technology and simplicity of use of our System.” 

About Micro Identification Technologies:

MIT is a California-based public company that has developed and patented a rapid microbial identification (ID) System that revolutionizes the pathogenic bacteria ID process and can annually save thousands of lives and tens of millions of dollars. The System IDs bacteria in minutes, not days, and at a significant per test cost savings when compared to any conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process is totally GREEN requiring only clean water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually — with food safety accounting for over $3 billion — having expanded at a rate of 9.2 percent annually since 1998. Current growth projections are at 30 percent annually with test demands driven by major health, safety and homeland security issues. www.micro-identification.com

MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. MIT has performed over 300 tests for the identification of the aforementioned contaminants and scored 95% accuracy. The System can currently identify 23 species of bacteria and is easily expandable. The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent, internationally recognized biological testing laboratory. The NAMSA Test Report is available from the Company and, in MIT’s opinion, demonstrates the accuracy, speed and cost effectiveness of the System over conventional processes. www.namsa.com

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

SUN VALLEY, CA–(Marketwire – October 22, 2010) –  XTend Medical (PINKSHEETS: XMDC), a company that specializes in delivering life changing medical technology to healthcare organizations globally, has secured the BioHarp patents as the agreement reached through mediation stated. The company released the following statement:

“XTend’s patent counsel, Knobbe, Martens, Olsen, & Bear, LLC, has successfully been able to secure the transfers of the patents associated with the BioHarp to XTend Medical. Now that the company has secured these patents, it can now move quickly to begin the commercialization of the BioHarp Medical device. The company has been in contact with several manufacturers interested in working closely with XTend to produce the BioHarp device. In addition, XTend continues to receive interest from numerous global distributors looking to bring the BioHarp into various countries for implementation into their healthcare programs wherein the BioHarp could play a large role in their future healthcare plans. In addition, veterinarian distributors in the U.S. and Europe feel the BioHarp could prove to be a valuable tool in pet care and have expressed a keen interest in working with XTend to sell and distribute the BioHarp. As the company progresses forward, exploring all of the opportunities presented for the BioHarp should assist the company in reaching its full potential in 2011 and beyond.”

About XTend Medical

XTend Medical is a company that specializes in the sales, manufacturing and distribution of the latest in medical devices and telemedicine solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their recent acquisition of the BioHarp medical device will assist the company in becoming known as a leader in the healthcare sector globally. For further information, please contact them at [email protected] or visit their website at www.bioharpunius.com

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.